Global Pneumococcal Vaccine Market Report 2022-2027: Rise in Government Focus on Immunization Programs for Pneumonia Fuels Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Pneumococcal Vaccine Market (2022-2027) by Type, Indication, Product, Distribution, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.

The Global Pneumococcal Vaccine Market is estimated to be USD 9.59 Bn in 2022 and expected to reach USD 13.49 Bn by 2027, growing at a CAGR of 7.07%.

Market Dynamics

Drivers

• Increasing Prevalence of Pneumococcal Contamination
• Upsurge in the Awareness Programs Regarding the Proper Vaccination
• Rise in Government Focus on Immunization Programs for Pneumonia

Restraints

• High Cost Associated with the Development of Pneumococcal Vaccines

Opportunities

• Rise in the Public-Private Partnerships to Provide Low-Cost Pneumococcal Vaccines
• Introduction of Novel Pneumococcal Vaccines

Challenges

• Inadequate Vaccine Coverage
• Slow Processing of Clinical Trials to Produce Vaccines

Market Segmentations

The Global Pneumococcal Vaccine Market is segmented based on Type, Indication, Product, Distribution, and Geography.

• By Type, the market is classified into Conjugate Vaccines and Polysaccharide Vaccines.
• By Indication, the market is classified into Bronchitis Meningitis and Bronchitis-Sepsis.
• By Product, the market is classified into Pneumovax23, Prevnar 13, and Synflorix.
• By Distribution, the market is classified into Government Authorities and Non-governmental Organizations.
• By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Pneumococcal Vaccine Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development, and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyzes the Global Pneumococcal Vaccine Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Pneumococcal Vaccine Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
• The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report also contains the competitive analysis using Positioning Quadrants, the analyst’s competitive positioning tool.

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics

5 Market Analysis

6 Global Pneumococcal Vaccine Market, By Type

7 Global Pneumococcal Vaccine Market, By Indication

8 Global Pneumococcal Vaccine Market, By Product

9 Global Pneumococcal Vaccine Market, By Distribution

10 Americas’ Pneumococcal Vaccine Market

11 Europe’s Pneumococcal Vaccine Market

12 Middle East and Africa’s Pneumococcal Vaccine Market

13 APAC’s Pneumococcal Vaccine Market

14 Competitive Landscape

15 Company Profiles

16 Appendix

Companies Mentioned

• Astellas Pharma, Inc.
• AstraZeneca PLC
• Beijing Minhai Biotechnology Corp. Ltd.
• BioNTech SE
• CSL Ltd.
• Emergent BioSolutions Inc.
• GSK PLC
• Johnson & Johnson
• LG Chem Ltd.
• Merck & Co., Inc.
• Panacea Biotec Ltd.
• Pfizer, Inc.
• Pnuvax Inc.
• Sanofi SA
• Serum Institute of India Pvt. Ltd.
• Shenzhen Kangtai Biological Products Co., Ltd.
• Sinovac Biotech Ltd.
• SK Bioscience
• Walvax Biotechnology Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/dgkuxo

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900